Analyst Reco. Enhabit, Inc.

Equities

EHAB

US29332G1022

Real-time Estimate Cboe BZX Other stock markets 01:47:28 2024-06-12 pm EDT			5-day change	1st Jan Change
9.635 ^USD	-0.16%		+4.56%	-6.96%

Jun. 11	Enhabit May Seeks Acquisitions	CI
Jun. 11	Transcript : Enhabit, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:00 AM

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Leerink Partners Upgrades Enhabit to Market Perform From Underperform, Price Target is $8.50	May. 14	MT
UBS Trims Price Target on Enhabit to $9 From $10, Keeps Neutral Rating	May. 10	MT
Jefferies Downgrades Enhabit to Hold From Buy, Price Target at $8.75	May. 09	MT
UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating	Mar. 08	MT
UBS Upgrades Enhabit to Neutral From Sell, $9.50 Price Target	Mar. 07	MT
Jefferies Adjusts Price Target on Enhabit to $14 From $15, Maintains Buy Rating	Mar. 06	MT
TD Cowen Starts Enhabit With Market Perform Rating	Dec. 12	MT
Credit Suisse Adjusts Enhabit's Price Target to $12 From $15, Keeps Neutral Rating	23-08-11	MT
Goldman Sachs Adjusts Price Target on Enhabit to $13 From $15, Maintains Neutral Rating	23-07-17	MT
UBS Adjusts Enhabit Price Target to $9.50 From $11, Maintains Sell Rating	23-05-12	MT
Goldman Sachs Starts Enhabit at Neutral With $15 Price Target	23-03-16	MT
CJS Securities Initiates Coverage on Enhabit With Market Perform Rating, $18 Price Target	22-12-13	MT
UBS Initiates Coverage on Enhabit With Sell Rating, $12 Price Target	22-12-08	MT
Stifel Starts Enhabit at Buy With $17 Price Target	22-12-06	MT
Credit Suisse Lowers Enhabit's Price Target to $15 From $19 on Further Mix Shift, Labor Cost Pressures; Keeps Neutral Rating	22-11-04	MT
Oppenheimer Initiates Coverage on Enhabit With Perform Rating	22-10-14	MT
Jefferies Initiates Enhabit at Buy with $20 Price Target	22-08-30	MT
Credit Suisse Initiates Enhabit at Neutral with $19 Price Target, Says Mid-to-High Single-Digit Annual Organic Growth Possible Long-Term	22-08-25	MT
RBC Cuts Price Target on Encompass Health to $66 From $82, Citing Enhabit Home Health & Hospice Spinoff, Maintains Outperform Rating	22-08-24	MT
Citigroup Initiates Enhabit at Neutral With $17 Price Target	22-08-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Enhabit, Inc.

Equities

EHAB

US29332G1022

Analyst Reco.

Filters